➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Harvard Business School
Moodys
Express Scripts
Baxter

Last Updated: December 1, 2020

DrugPatentWatch Database Preview

Litigation Details for Pfizer Inc. v. Fresenius Kabi USA LLC (D. Del. 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Pfizer Inc. v. Fresenius Kabi USA LLC (D. Del. 2013)

Docket   Start Trial Date Filed 2013-11-13
Court District Court, D. Delaware Date Terminated 2015-11-24
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To Sherry R. Fallon
Parties ASSIA CHEMICAL INDUSTRIES LTD., TEVA-TECH SITE; FRESENIUS KABI USA LLC; PF PRISM C.V.; PFIZER INC.; PFIZER MANUFACTURING HOLDINGS LLC; PFIZER PHARMACEUTICALS LLC; TEVA API, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.; WYETH HOLDINGS CORPORATION; WYETH HOLDINGS LLC; WYETH LLC
Patents 7,879,828; 8,372,995; RE4183
Attorneys Adam J. Diederich; Ahmed M. Riaz; Craig Crockett; David A. Bilson; Gina M. Bassi; Imron T. Aly; Jack B. Blumenfeld; Jeremy A. Tigan; Joel M. Wallace; John C. Phillips , Jr.; Maryellen Noreika; Megan C. Haney
Link to Docket External link to docket
Small Molecule Drugs cited in Pfizer Inc. v. Fresenius Kabi USA LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Pfizer Inc. v. Fresenius Kabi USA LLC (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2015-03-30 166 Joint STIPULATION Regarding U.S. Patent No. RE40,183 by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing… 24 November 2015 1:13-cv-01893 830 Patent None District Court, D. Delaware External link to document
2015-11-23 213 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE40,183 E; 7,879,282 B2; 8,372,995 B2. (Attachments… 24 November 2015 1:13-cv-01893 830 Patent None District Court, D. Delaware External link to document
2014-05-12 25 Notice of Service Infringement Contentions for U.S. Patent Nos. RE40,183; 7,879,828; and 8,372,995 filed by PF Prism C.… 24 November 2015 1:13-cv-01893 830 Patent None District Court, D. Delaware External link to document
2013-11-13 3 ANDA Form 10/2/2013. Date of Expiration of Patent: RE 40,183-4/9/2016; 7,879,828-2/5/2029; 8,372,995-10/8/2030.Thirty… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 24 November 2015 1:13-cv-01893 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Merck
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.